Voronoi, Inc. 310210.KQ · Stock Open Voronoi, Inc. in new tab
Voronoi, Inc. Analysis (310210.KQ)
Is Voronoi, Inc. a good investment? Voronoi, Inc. (310210.KQ) is currently trading at 250000.00 KRW. Market analysts have a consensus price target of 350000.00 KRW. This suggests a potential upside from current levels.
Investor FAQ
Does Voronoi, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Voronoi, Inc.?
Voronoi, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
Company Profile
Voronoi, Inc. researches, develops, and discovers small molecule kinase inhibitors in South Korea. Its products pipeline includes VRN01, an oral leucine rich repeat kinase 2 inhibitor targeting glioblastoma multiforme to treat brain and pancreatic cancers; VRN07, VRN06, and VRN11 for the treatment of lung cancer; VRN08 and VRN10 to treat breast cancer; and VRN02 for the treatment of rheumatoid arthritis and atopic dermatitis. The company's products pipeline also comprise VRN04-1 to treat autoimmune diseases; VRN04-2 for the treatment of multiple sclerosis and amyotrophic lateral sclerosis; VRN13 to treat pulmonary arterial hypertension; and VRN14 for the treatment of refractory solid cancer. Voronoi, Inc. was incorporated in 2015 and is based in Incheon, South Korea.
| Split Date | Split Ratio to 1 |
|---|---|
| Sept. 13, 2023 | 1.200000 |
| Sept. 14, 2023 | 1.200000 |
Community Discussion